Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
10/1995
10/24/1995US5460953 Vectors and compounds for expression of glycosylation mutants of human protein C
10/24/1995US5460951 Bone-related carboxypeptidase-like protein and process for its production
10/24/1995US5460950 Expression of PACE in host cells and methods of use thereof
10/24/1995US5460949 Method and composition for increasing the accumulation of squalene and specific sterols in yeast
10/24/1995US5460942 Isolated nucleic acid selectively hybridizing to nucleic acid encoding catalytic moiety of human glucose-6-phosphatase system or mutation
10/24/1995US5460941 Method of targeting DNA
10/24/1995US5460810 Method for maintaining gut epithelial cells by treatment with a cytokine such as interleukin 11
10/24/1995CA1337405C Purified thermostable enzyme
10/22/1995CA2121898A1 Synthesis of prototypes for renin inhibitors
10/19/1995WO1995027825A1 Preparation process of paper for increasing filler contents and enhancing scott internal bond strength
10/19/1995WO1995027793A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICErel-II)
10/19/1995WO1995027792A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICErel-III)
10/19/1995WO1995027791A1 Plant lysophosphatidic acid acyltransferases
10/19/1995WO1995027790A2 DNA SEQUENCES CODING FOR A CYNNAMOYL CoA REDUCTASE AND THEIR USE IN THE REGULATION OF PLANT LIGNIN CONCENTRATIONS
10/19/1995WO1995027789A1 Cloning and expression of human gmp synthetase, its use in screening for inhibitors of human gmp synthetase and inhibitors of human gmp synthetase
10/19/1995WO1995027784A1 Cisplatin resistance gene and uses therefor
10/19/1995WO1995027781A1 Superoxide dismutase-4
10/19/1995WO1995027779A1 Bacterial xylanase
10/19/1995WO1995027735A1 Apoptose inhibitor
10/19/1995WO1995027506A1 Catalase-based anti-helicobacter pylori immunising composition
10/19/1995WO1995016044A3 Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules
10/19/1995WO1994028145A3 Expression of urokinase plasminogen activator inhibitors
10/19/1995DE4412692A1 New cycloalkane oxime derivs.
10/19/1995DE4412691A1 Hetero-arylidene- and heteroaryl-alkyl- 1-aza:cycloalkane
10/19/1995DE4412372A1 Bovine and human endothelin converting enzymes and corresp. DNA
10/19/1995CA2187635A1 Superoxide dismutase-4
10/19/1995CA2185334A1 Dna sequences coding for a cynnamoyl coa reductase and their use in the regulation of plant lignin concentrations
10/19/1995CA2164729A1 Catalase-based anti-helicobacter pylori immunising composition
10/19/1995CA2163526A1 Cisplatin resistance gene and uses therefor
10/18/1995EP0677586A1 Recombinant collagenase type II from clostridium histolyticum and its use for the isolation of cells and cellular agglomerations
10/18/1995EP0677585A1 Process for the production of D-alpha-amino acids
10/18/1995EP0677584A1 Stable mutants of D-N-alpha-carbamylase
10/18/1995EP0677581A1 Dna coding for plant-derived atp-dependent fructose-6-phosphate 1-phosphotransferase, recombinant vector containing the same, and method of changing sugar content of plant cell by using the vector at low temperature
10/18/1995EP0677516A1 Cyclic amide derivatives
10/18/1995EP0677115A1 Tia-1 binding proteins and isolated complementary dna encoding the same
10/18/1995EP0677112A1 Method for obtaining transgenic plants showing a modified fructan pattern
10/18/1995EP0677108A1 Method for breeding disease resistance into plants
10/18/1995EP0677107A1 Clotting inhibitor made from protostomia saliva.
10/18/1995EP0677102A1 Enhancement of enzyme reactions
10/18/1995EP0677063A1 A NEW CLASS OF RPTPases: THEIR STRUCTURAL DOMAINS AND LIGANDS
10/18/1995EP0677053A1 Enhanced yeast expression using regulatory control sequences from yeast sorbitol dehydrogenase gene
10/18/1995EP0677044A1 $i(IN VIVO) METHOD OF OBTAINING CELL COMPONENTS
10/18/1995EP0677039A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
10/18/1995EP0676964A1 Nitrosylation of protein sh groups and amino acid residues as a therapeutic modality
10/18/1995EP0620709B1 Process for isolating lactoferrin and lactoperoxidase from milk and milk products
10/18/1995EP0555203B1 Expression induction method employing dhfr gene
10/18/1995EP0501949B1 Purification of q beta replicase
10/18/1995EP0291533B1 Rna ribozyme restriction endoribonucleases and methods
10/18/1995CN1110322A De-esterification method using pectinestrase of oranges and tangerines peel and its application
10/18/1995CN1110318A High effective compound plant beta-amylase
10/17/1995US5459255 For incorporation into oligonucleotides, cleaving RNA site specifically
10/17/1995US5459248 Process of preparing etoposide phosphate and etoposide
10/17/1995US5459239 For identification and quantification biological samples
10/17/1995US5459064 Derived from bacillus licheniformis, encoded by specified, purified dna sequences and cleaves peptide bonds
10/17/1995US5459063 Antimalarial agents
10/17/1995US5459062 Gram-negative alkaliphilic microorganisms
10/17/1995US5459055 Thermostable ribonuclease H isolated from Thermus flavus
10/17/1995US5459051 Genetic engineering, gene expression
10/17/1995US5459036 Extracellular signal-regulated kinase, sequences, and methods of production and use
10/17/1995US5459015 High-affinity RNA ligands of basic fibroblast growth factor
10/17/1995US5458874 Method of increasing monocyte chemotaxis with CAP37 and monocyte chemotactic portions thereof
10/12/1995WO1995027070A1 Dna expression vectors for use in the treatment of vascular diseases by gene therapy
10/12/1995WO1995027069A1 Alphavirus rna as carrier for vaccines
10/12/1995WO1995027067A1 Purified dna polymerase from bacillus stearothermophilus
10/12/1995WO1995027066A2 Dna encoding ubiquitin conjugating enzymes
10/12/1995WO1995027065A1 Method for selecting transformed eucaryotic cells and cells obtained thereby
10/12/1995WO1995027064A1 Ethanol production by transformation of gram-positive microbes
10/12/1995WO1995027061A1 Protein tyrosine kinase agonist antibodies
10/12/1995WO1995027058A1 MOLECULAR CLONING AND EXPRESSION OF A η-INTERFERON INDUCIBLE ACTIVATOR OF THE PROTEASOME
10/12/1995WO1995027055A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY
10/12/1995WO1995027053A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING CHYMASE INHIBITING ACTIVITY
10/12/1995WO1995027051A1 Modified gad, a method for manufacturing of modified gad and a method to supply modified gad and peptide
10/12/1995WO1995027050A1 A method of preparing recombinant streptokinase
10/12/1995WO1995027049A1 High-alkaline protease and its use
10/12/1995WO1995027047A2 Highly-purified recombinant reverse transcriptase
10/12/1995WO1995027046A2 Enzymatic antimicrobial compositions containing haloperoxidases
10/12/1995WO1995027045A1 The isolation and production of catalytic antibodies using phage technology
10/12/1995WO1995027009A1 Antifouling paint containing haloperoxidases and method to determine halide concentrations
10/12/1995WO1995026973A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects
10/12/1995WO1995026743A1 Nadh oxidase as a target in diagnosis and therapy
10/12/1995WO1995026736A1 Use of biopolymers for the muscle treatment
10/12/1995WO1995019443A3 Chemically regulatable and anti-pathogenic dna sequences and uses thereof
10/12/1995CA2187200A1 Nadh oxidase as a target in diagnosis and therapy
10/12/1995CA2187170A1 Method for selecting transformed eucaryotic cells and cells obtained thereby
10/12/1995CA2186908A1 .alpha.-1-antichymotrypsin analogues having elastase inhibitory activity
10/12/1995CA2186636A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects
10/12/1995CA2186635A1 .alpha.-1-antichymotrypsin analogues having chymase inhibiting activity
10/12/1995CA2182966A1 Enzymatic antimicrobial compositions
10/11/1995EP0676473A2 Almond n-glycosidase gene
10/11/1995EP0676472A1 Human manganese superoxide dismutase (hMn-SOD)
10/11/1995EP0676471A2 Effector proteins of rapamycin
10/11/1995EP0676414A1 Lipases immobilized in sol-gel processed hydrophobic materials
10/11/1995EP0676145A1 Coffee hydrolysis with immobilised beta-mannanase
10/11/1995EP0675964A1 HUMAN CYCLOOXYGENASE-2cDNA AND ASSAY FOR EVALUATING INHIBITION OF CYCLOOXYGENASE-2.
10/11/1995EP0675960A1 Plants genetically enhanced for disease resistance
10/11/1995EP0675958A1 Nucleotide sequence encoding carbamoyl phosphate synthetase ii
10/11/1995EP0675955A1 Molecular flashlight
10/11/1995EP0675954A1 Deblocking the common pathway of aromatic amino acid synthesis
10/11/1995EP0675952A1 Process for dust-free enzyme manufacture
10/11/1995EP0675951A1 An enzyme with endoglucanase activity
1 ... 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 ... 1416